Unique and optimized solution provides highly sensitive and reproducible RNA amplification and labeling from archived FFPE samples for biomarker discovery and validation on industry-leading ...
SAN DIEGO & SANTA CLARA, Calif., Jan 10, 2008 - Affymetrix and Illumina, Inc. (NASDAQ:ILMN) announced today that they have entered into a settlement agreement to resolve their patent litigation. Under ...
(NASDAQ: AFFX) today announced the expansion of its license agreement with Siemens Healthcare Diagnostics for the company’s branched DNA (bDNA) technology whereby Affymetrix is the exclusive licensee ...
Affymetrix Inc. of Santa Clara won the race Thursday to market a single gene chip packed with fragments from each of the 35,000 known genes that make up the human genome. But two other Bay area ...
On June 25, genetic products maker Affymetrix Inc (AFFX) completed its acquisition of eBioscience Holding Company, Inc. for $315 million in cash. The payment was partly financed through available cash ...
Affymetrix expects the acquisition of eBioscience to: • Create significant new commercial opportunities in the key post-genomic applications of immunology, oncology, cell biology, stem cell biology, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback